
Two in five pharmacists say work harms their wellbeing
A PDA survey has found that two in five pharmacists report their work significantly impacts their wellbeing. The PDA says mental health-related absences in the profession are underreported, suggesting the real picture may be worse than the headline figure.
What happened
The Pharmacists' Defence Association published survey findings showing that a substantial proportion of pharmacists experience a significant negative effect on their wellbeing from their work. The PDA drew attention not just to the scale of the problem but to how it is being captured — or rather, how it isn't. The organisation stated that mental health-related absences are "underreported", which means the data available to employers, regulators, and workforce planners likely understates how serious the situation is.
The findings point to sustained pressure across the profession rather than isolated incidents. Two in five is a large share of any workforce. In a regulated healthcare profession where decision-making directly affects patient safety, the implications stretch beyond individual wellbeing.
Why it matters
Pharmacy is often discussed in terms of workload, short staffing, and funding pressures. What this survey makes concrete is the human cost of those structural problems. A pharmacist who is struggling with their wellbeing does not stop being responsible for the prescriptions they check, the advice they give, or the clinical judgements they make. The professional obligations remain constant even when the person carrying them is under strain.
The underreporting point is worth sitting with. When mental health-related absences go unreported — whether because of stigma, fear of professional consequences, or a culture that discourages disclosure — the problem becomes invisible to the systems that might otherwise respond to it. Employers don't see the true picture. Workforce data doesn't reflect it. And so the pressure continues, often justified by the apparent ability of the existing workforce to cope.
For anyone entering the profession now, this is the environment they're stepping into. Pre-registration trainee pharmacists are not immune to the pressures described here. Training periods can be demanding, with exam preparation running alongside workplace learning, both under time pressure. The question of how to protect your own wellbeing — and where to seek support — is not a secondary concern. It belongs alongside clinical and professional development.
There is also a broader professional responsibility angle. Pharmacists are required by the GPhC to practise safely and effectively. If work conditions are significantly affecting wellbeing, that has direct relevance to a pharmacist's ability to meet that standard — and to whether they have a professional duty to escalate concerns about those conditions, not just absorb them.
GPhC exam relevance
The GPhC Standards for Pharmacy Professionals require registrants to be honest and trustworthy, to act in the best interests of patients, and to speak up when they have concerns. The wellbeing findings connect to these standards in a specific way: a pharmacist who is struggling but stays silent — about their own condition or about unsafe working conditions — may be acting against those standards, even if their instinct is to protect their job or avoid conflict.
The exam tests candidates on professional accountability and the duty to raise concerns. Questions can be framed around scenarios where a colleague appears unwell, where workload is unsafe, or where a pharmacist must decide whether to flag a problem to a manager, superintendent, or regulator. Understanding that the professional obligation to speak up applies to wellbeing and working conditions — not only to dispensing errors or clinical concerns — is a distinction worth being clear on.
The underreporting of mental health-related absences also connects to honesty and transparency requirements. Registrants are expected to be open about factors that may affect their fitness to practise. If a pharmacist is experiencing significant mental health difficulties and those are affecting their work, disclosure — to an appropriate person, in an appropriate way — is part of meeting that standard.
Scenario-based questions sometimes include situations involving a pharmacist under obvious stress, making errors, or asking colleagues to cover for reduced capacity. The correct course of action in those scenarios is shaped by the standards, not by what might seem easier in the moment.
What's next
The PDA's findings are likely to feed into wider conversations about pharmacy workforce conditions, including ongoing discussions about pay, staffing ratios, and the sustainability of community pharmacy. Trainees should watch for any formal response from employers, NHS England, or the GPhC to this kind of sector-wide evidence.
On a practical level, if you are a trainee experiencing significant pressure, know that raising concerns with your designated supervisor or responsible pharmacist is not weakness — it is exactly what the standards ask of you. Keeping a record of incidents, near-misses, or periods of particular stress is also sound practice, both for your own reflective learning and in case concerns need to be escalated later.
The gap between what pharmacists experience and what appears in official data is a problem for the profession as a whole. Closing that gap starts with individuals being willing to report accurately, and with employers creating conditions where that feels safe to do.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/news/two-in-five-pharmacists-say-work-significantly-impacts-wellbeing-2BST6RYTKVHVLAL375LG4SNJJU/